Citation Impact
Citing Papers
Sensitization of Human Carcinoma Cells to Alkylating Agents by Small Interfering RNA Suppression of 3-Alkyladenine-DNA Glycosylase
2005 StandoutNobel
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Similar Nucleotide Excision Repair Capacity in Melanocytes and Melanoma Cells
2010 StandoutNobel
Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer
2015 StandoutNobel
The specific contribution of hypoxia-inducible factor-2α to hypoxic gene expression in vitro is limited and modulated by cell type-specific and exogenous factors
2008
Interferon-γ regulates cellular metabolism and mRNA translation to potentiate macrophage activation
2015 StandoutNobel
Discovery and optimization of a highly efficacious class of 5-aryl-2-aminopyridines as FMS-like tyrosine kinase 3 (FLT3) inhibitors
2015
Cbfβ-SMMHC induces distinct abnormal myeloid progenitors able to develop acute myeloid leukemia
2006
An immune edited tumour versus a tumour edited immune system: prospects for immune therapy of acute myeloid leukaemia
2006
Use of arsenic trioxide (As2O3) in the treatment of patients with acute promyelocytic leukemia
2003 Standout
Stem cells, cancer, and cancer stem cells
2001 StandoutNature
Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations for acute myeloid leukemia: a meta-analysis
2005
IL-1R and MyD88 Contribute to the Absence of a Bacterial Microbiome on the Healthy Murine Cornea
2018 StandoutNobel
In vitro selection, characterization, and application of deoxyribozymes that cleave RNA
2005
From Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation
2014 Standout
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
1994 StandoutNature
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
2001 Standout
The M1 and M2 paradigm of macrophage activation: time for reassessment
2014 Standout
The biology and function of fibroblasts in cancer
2016 Standout
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
2004 Standout
Mechanisms of therapy-related carcinogenesis
2005
Anticancer activities of histone deacetylase inhibitors
2006 Standout
Immune attack: the role of inflammation in Alzheimer disease
2015 Standout
Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia
2002
Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology
2006 Standout
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission – experience on safety and efficacy within a randomized multicenter phase III trial of the German CLL Study Group (GCLLSG)
2004
Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease
1999
Tyrosinase mRNA levels in the blood of uveal melanoma patients: correlation with the number of circulating tumor cells and tumor progression
2010
Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML)
2006
Mismatch repair and response to DNA-damaging antitumour therapies
2003
Detection of minimal residual disease
2001
Deoxyribozymes: useful DNA catalysts in vitro and in vivo
2008
PU.1 and Interferon Consensus Sequence-binding Protein Regulate the Myeloid Expression of the Human Toll-like Receptor 4 Gene
2000 StandoutNobel
Ongoing Revolution in Bacteriology: Routine Identification of Bacteria by Matrix‐Assisted Laser Desorption Ionization Time‐of‐Flight Mass Spectrometry
2009 Standout
Biology and management of relapsed acute myeloid leukaemia
2005
The Biology of Chronic Myeloid Leukemia
1999
Frequency of CBFβ/MYH11 fusion transcripts in patients entered into the U.K. MRC AML trials
1997
The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia
2001
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
2001 Standout
Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program
2003
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
Therapy-Related Myeloid Leukemia
2008
Reactive Astrocytes: Production, Function, and Therapeutic Potential
2017 Standout
The role of senescent cells in ageing
2014 StandoutNature
TP53 allele loss, mutations and expression in malignant melanoma
1994
Macrophage M1/M2 polarization
2020 Standout
Quantitative real-time RT-PCR analysis of PML-RARalpha mRNA in acute promyelocytic leukemia: assessment of prognostic significance in adult patients from intergroup protocol 0129
2002
Cancer as an evolutionary and ecological process
2006 Standout
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Impact of Cytogenetics on Outcome of De Novo and Therapy-Related AML and MDS after Allogeneic Transplantation
2007
Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology
2013
Circulating Cancer Cells in Peripheral Blood
2000
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Advances in the understanding of susceptibility to treatment‐related acute myeloid leukaemia
2007
Functional Characterization of FLT3 Receptor Signaling Deregulation in Acute Myeloid Leukemia by Single Cell Network Profiling (SCNP)
2010
Direct Detection of Bacterial Biofilms on the Middle-Ear Mucosa of Children With Chronic Otitis Media
2006 Standout
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
2003 Standout
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
Comparison of Cytogenetic and Molecular Genetic Detection of t(8;21) and inv(16) in a Prospective Series of Adults With De Novo Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
2001
Functional Nucleic Acid Sensors
2009 Standout
United States Multicenter Study of Arsenic Trioxide in Relapsed Acute Promyelocytic Leukemia
2001 Standout
Macrophage Polarization
2016 Standout
Genetic Diagnosis and Molecular Monitoring in the Management of Acute Promyelocytic Leukemia
1999
Epigenetic and Chromatin Modifiers As Targeted Therapy of Hematologic Malignancies
2005
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
Chronic Postoperative Endophthalmitis: A Review of Clinical Characteristics, Microbiology, Treatment Strategies, and Outcomes
2012
AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation
2000
Three-dimensional organization of promyelocytic leukemia nuclear bodies
2010 StandoutNobel
The B7 Family and Cancer Therapy: Costimulation and Coinhibition
2007 StandoutNobel
Detection of Prosthetic Hip Infection at Revision Arthroplasty by Immunofluorescence Microscopy and PCR Amplification of the Bacterial 16S rRNA Gene
1999
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
2009 Standout
Analysis of 525 Samples To Determine the Usefulness of PCR Amplification and Sequencing of the 16S rRNA Gene for Diagnosis of Bone and Joint Infections
2006
The macrophage transcription factor PU.1 directs tissue-specific expression of the macrophage colony-stimulating factor receptor.
1994
Therapy of Molecular Relapse in Acute Promyelocytic Leukemia
1999
Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of Americaa
2012 Standout
Autologous Stem Cell Transplantation in Acute Myelocytic Leukemia
1998
Presenting White Blood Cell Count and Kinetics of Molecular Remission Predict Prognosis in Acute Promyelocytic Leukemia Treated With All-Trans Retinoic Acid: Result of the Randomized MRC Trial
1999
The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials
2001 Standout
Molecular Analysis of Bacterial Pathogens in Otitis Media With Effusion
1995
Autologous Stem Cell Transplantation in Acute Myelocytic Leukemia
1998
Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum
2011 StandoutScience
Clinical microbiology of coryneform bacteria
1997 Standout
Cataracts
2017 Standout
Hematopoietic growth factors and their receptors in acute leukemia
1993
Development of Minimal Residual Disease–Directed Therapy in Acute Myeloid Leukemia
2008
FLT3 tyrosine kinase domain mutations are biologically distinct from and have a significantly more favorable prognosis than FLT3 internal tandem duplications in patients with acute myeloid leukemia
2007
Prosthetic Joint Infection
2014 Standout
Microglial M1/M2 polarization and metabolic states
2015 Standout
Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma
2007 Standout
The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial
1998 Standout
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
16S rDNA-based identification of bacteria from conjunctival swabs by PCR and DGGE fingerprinting.
2001
Deconstructing a Disease: RAR, Its Fusion Partners, and Their Roles in the Pathogenesis of Acute Promyelocytic Leukemia
1999
Works of Khalid Tobal being referenced
Detection and quantitation of the CBFβ/MYH11 transcripts associated with the inv(16) in presentation and follow-up samples from patients with AML
1997
Screening for EGFR and KRAS Mutations in Endobronchial Ultrasound Derived Transbronchial Needle Aspirates in Non-Small Cell Lung Cancer Using COLD-PCR
2011
Prognostic significance of FLT3 ITD and D835 mutations in AML patients
2003
The diagnosis of delayed post-operative endophthalmitis by polymerase chain reaction of bacterial DNA in vitreous samples
1994
Humoral detection of leukaemia-associated antigens in presentation acute myeloid leukaemia
2005
Detection of minimal residual disease in acute myeloid leukaemia: methodologies, clinical and biological significance
1999
Prognostic significance of quantitative analysis of WT1 gene transcripts by competitive reverse transcription polymerase chain reaction in acute leukaemia
2003
Increased expression and mutation of p53 in choroidal melanoma
1992
Expression of AML1/MTG8 transcripts in clonogenic cells grown from bone marrow of patients in remission of acute myeloid leukaemia with t(8;21)
1997
Detection of CBFB/MYH11 transcripts in patients with inversion and other abnormalities of chromosome 16 at presentation and remission
1995
Molecular Monitoring of Minimal Residual Disease in Acute Myeloblastic Leukemia with t(8;21) by RT-PCR
1998
Targeting PML/RARα transcript with DNAzymes results in reduction of proliferation and induction of apoptosis in APL cells
2004
Persistence of RARa‐PML fusion mRNA detected by reverse transcriptase polymerase chain reaction in patients in long‐term remission of acute promyelocytic leukaemia
1995
Mutation of the human FMS gene (M-CSF receptor) in myelodysplastic syndromes and acute myeloid leukemia.
1990
Quantification of DEK-CAN fusion transcript by real-time reverse transcription polymerase reaction in patients with t(6;9) acute myeloid leukemia.
2004
High level of microsatellite instability but not hypermethylation of mismatch repair genes in therapy‐related and secondary acute myeloid leukaemia and myelodysplastic syndrome
2002
Monitoring of minimal residual disease by quantitative reverse transcriptase-polymerase chain reaction for AML1-MTG8 transcripts in AML-M2 with t(8; 21)
1996
RT-PCR method with increased sensitivity shows persistence of PML-RARA fusion transcripts in patients in long-term remission of APL
1998
Molecular quantitation of minimal residual disease in acute myeloid leukemia with t(8;21) can identify patients in durable remission and predict clinical relapse
2000
Detection of melanocytes from uveal melanoma in peripheral blood using the polymerase chain reaction.
1993